SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000919574-17-001453
Filing Date
2017-02-13
Accepted
2017-02-13 16:39:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 d7412442_13g-a.htm SC 13G/A 166043
  Complete submission text file 0000919574-17-001453.txt   167880
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Aviragen Therapeutics, Inc. (Subject) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G/A | Act: 34 | File No.: 005-31596 | Film No.: 17599846
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 400 MADISON AVENUE SUITE 14D NEW YORK NY 10017
Business Address 400 MADISON AVENUE SUITE 14D NEW YORK NY 10017 646-545-4618
SENZAR ASSET MANAGEMENT, LLC (Filed by) CIK: 0001579853 (see all company filings)

IRS No.: 450929151 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A